Non-Destructive Spectroscopic Assessment of Bone Water at Microscopic Resolution

微观分辨率下骨水的无损光谱评估

基本信息

  • 批准号:
    9308435
  • 负责人:
  • 金额:
    $ 17.04万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-03-01 至 2019-01-31
  • 项目状态:
    已结题

项目摘要

Bone fracture risk increases with age, disease states (e.g. osteoporosis, osteogenesis imperfecta (OI), renal osteodystrophy, and diabetes) and with use of certain therapeutics, such as acid-suppressive drugs, steroids and high-dose bisphosphonates. Historically, investigations into factors that underlie bone fracture risk have focused on evaluation of areal bone mineral density (aBMD). Accordingly, current clinical practice utilizes assessment of aBMD by dual-energy X-ray absorptiometry (DXA) as the main modality for prediction of fracture risk. However, numerous studies have pointed to factors other than bone mineral density (BMD) that contribute to fragility, including changes in bone collagen and water. The role of water in bone fragility has primarily been addressed through evaluation of mechanical properties of harvested bone in its native hydrated state followed by dehydration. Together, these studies clearly demonstrated that the amount of water within the bone composite structure correlates to mechanical parameters, including strength, toughness, strain, and stiffness, but a specific mechanism for the interaction of the water with the mineral and collagen phases of bone has not been established. A main limitation for investigation of these mechanisms is the lack of a non-destructive gold standard technique for assessment of water in bone, and in particular, at a microscopic resolution level. The current study proposes the development of a near infrared spectroscopic (NIRS) method for evaluation of specific water compartments in bone at microscopic resolution for preclinical studies. NIRS is a technique based on molecular vibrations, has been used effectively in the analysis of molecular content in connective tissues, and is widely used in the pharmaceutical and food industries as the reference standard for non- invasive evaluation of water. Here, we will extend these NIRS imaging techniques to quantify water content at the microscopic scale in bone, including determination of the molecular species that water is bound to. We propose to use NIRS to assess the binding of water to the primary matrix components of bone, hydroxyapatite mineral and collagen, and to intact bone, including mouse bone with a collagen defect. Together, these experiments will extend the technique of NIR spectral imaging to quantitative molecular-level assessment of water in bone. This will enable extension of this technique to guide assessment of bone fragility and therapeutic interventions such as bone repair.
骨折风险随着年龄、疾病状态(例如骨质疏松症、成骨不全(OI)、肾功能衰竭)、骨质疏松症、 骨营养不良和糖尿病)和使用某些治疗剂,例如抑酸药物、类固醇 和高剂量的双膦酸盐从历史上看,对骨折风险因素的研究 重点是评估区域骨密度(aBMD)。因此,目前的临床实践利用 双能X线骨密度仪(DXA)评估aBMD作为预测 骨折风险。然而,许多研究指出,骨矿物质密度(BMD)以外的因素, 导致脆弱性,包括骨胶原和水的变化。 水在骨脆性中的作用主要是通过评价骨的力学性能来解决的。 在其天然水合状态下采集骨,然后脱水。总之,这些研究显然 表明骨复合结构内的水量与机械强度相关, 参数,包括强度,韧性,应变和刚度,但相互作用的具体机制, 具有骨的矿物质和胶原相的水尚未被确定。一个主要的限制, 这些机制的调查是缺乏一个非破坏性的金标准技术评估 骨中的水,特别是在微观分辨率水平上。 本研究提出了一种近红外光谱(NIRS)方法的发展,用于评估 用于临床前研究的显微镜分辨率下骨中的特定水隔室。NIRS是一种技术, 基于分子振动原理,已被有效地用于连接物分子含量的分析 组织,并广泛用于制药和食品工业作为非- 水的侵入性评价。在这里,我们将扩展这些近红外成像技术,以量化水含量, 骨骼中的微观尺度,包括确定与水结合的分子种类。我们 建议使用NIRS评估水与骨的主要基质成分羟基磷灰石的结合 矿物质和胶原蛋白,以及完整的骨,包括具有胶原蛋白缺陷的小鼠骨。所有这些 实验将扩展近红外光谱成像技术的定量分子水平的评估, 骨头里的水这将使该技术能够扩展到指导骨脆性评估, 治疗干预,例如骨修复。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nancy Pleshko其他文献

Nancy Pleshko的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Nancy Pleshko', 18)}}的其他基金

Evaluation of cartilage tissue engineering strategies by IR imaging
通过红外成像评估软骨组织工程策略
  • 批准号:
    8264380
  • 财政年份:
    2009
  • 资助金额:
    $ 17.04万
  • 项目类别:
Evaluation of Cartilage Tissue Engineering Strategies by IR Imaging
通过红外成像评估软骨组织工程策略
  • 批准号:
    9926711
  • 财政年份:
    2009
  • 资助金额:
    $ 17.04万
  • 项目类别:
Evaluation of Cartilage Tissue Engineering Strategies by IR Imaging
通过红外成像评估软骨组织工程策略
  • 批准号:
    9185759
  • 财政年份:
    2009
  • 资助金额:
    $ 17.04万
  • 项目类别:
Evaluation of Cartilage Tissue Engineering Strategies by IR Imaging
通过红外成像评估软骨组织工程策略
  • 批准号:
    9326141
  • 财政年份:
    2009
  • 资助金额:
    $ 17.04万
  • 项目类别:
Evaluation of cartilage tissue engineering strategies by IR imaging
通过红外成像评估软骨组织工程策略
  • 批准号:
    7901081
  • 财政年份:
    2009
  • 资助金额:
    $ 17.04万
  • 项目类别:
Evaluation of Cartilage Tissue Engineering Strategies by IR Imaging
通过红外成像评估软骨组织工程策略
  • 批准号:
    9402967
  • 财政年份:
    2009
  • 资助金额:
    $ 17.04万
  • 项目类别:
Evaluation of cartilage tissue engineering strategies by IR imaging
通过红外成像评估软骨组织工程策略
  • 批准号:
    8088040
  • 财政年份:
    2009
  • 资助金额:
    $ 17.04万
  • 项目类别:
Evaluation of cartilage tissue engineering strategies by IR imaging
通过红外成像评估软骨组织工程策略
  • 批准号:
    7559112
  • 财政年份:
    2009
  • 资助金额:
    $ 17.04万
  • 项目类别:
Infrared fiber optic imaging of degenerative cartilage
退行性软骨的红外光纤成像
  • 批准号:
    7934494
  • 财政年份:
    2002
  • 资助金额:
    $ 17.04万
  • 项目类别:
Infrared fiber optic imaging of degenerative cartilage
退行性软骨的红外光纤成像
  • 批准号:
    7664497
  • 财政年份:
    2002
  • 资助金额:
    $ 17.04万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 17.04万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.04万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 17.04万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.04万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 17.04万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 17.04万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.04万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 17.04万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 17.04万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.04万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了